About

Adimab is the technology leader in the discovery and optimization of fully human therapeutic antibodies.

With more than 30 antibody discovery projects in the last three years, Adimab has become the industry’s most sought after partner for the development of therapeutic human antibodies. Adimab has enabled its partners, including Biogen Idec, Eli Lilly, Genentech, Gilead, Human Genome Sciences, Merck, Novartis, Novo Nordisk, Pfizer, and Roche to expand their biologics pipelines through a range of technology access arrangements. Less than three years after Adimab launched its platform several antibodies discovered by Adimab have entered human clinical trials providing further evidence for the quality and speed of the platform.

Contact Info

7 Lucent Drive, Lebanon, NH, 03766
Tel: 603-643-7110
www.adimab.com

Polaris Lead

Terry McGuire

Social Media